4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Science. Official publication website can be found on muni.cz.

Authors	BRYJA Vítězslav JANOVSKÁ Pavlína GREGOROVÁ Michaela NĚMEC Václav KHIRSARIYA PrashantKumar PARUCH Kamil
Year of publication	2022
Type	Patent
MU Faculty or unit	Faculty of Science
Publisher	United States Patent and Trademark Office
State	United States of America
Patent's number	US11498920
web	https://worldwide.espacenet.com/patent/search/family/061837684/publication/US11498920B2?q=US11498920B2
Description	Novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds that are useful in the treatment of lymphomas, leukaemias, and solid tumors.
Related projects:	Preclinical Progression of New Organic Compounds with Targeted Biological Activity CZ-OPENSCREEN: National Infrastructure for Chemical Biology